MYTAY yields 24.15% · MRK yields 2.76%● Live data
📍 MYTAY pulled ahead of the other in Year 1
Combined, MYTAY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MYTAY + MRK for your $10,000?
Magyar Telekom Távközlési Nyilvánosan Müködö Részvénytársaság provides fixed-line and mobile telecommunication services for residential and small business customers in Hungary, Bulgaria, Romania, and the Republic of North Macedonia. The company operates in MT-Hungary and North Macedonia segments. It offers TV distribution, information communication, and system integration services; mobile telecommunication services, such as prepaid and postpaid plans, data plans, TV, broadband, SMS, and phone services; internet and voice, Office 365, server and data park, and machine to machine services; and sells telecommunications network and equipment. The company also provides mobile services comprising mobile tariff plans and mobilnet; IT services, including modern office, business support and security, communication solutions, IT devices, servers, and data pack services; and IoT services and data transmission solutions. In addition, it offers fixed line wholesale services comprising access, IP and data, voice, and TV services; mobile wholesale services, such as mobile interconnect and interworking products, and roaming services; international wholesale voice and data services, as well as IPv6 dual-stack services to its residential customers. Further, the company provides system integration and IT services, as well as operates as an interactive service provider of telecommunications applications and telebikes community. It offers its services under the Telekom and T-Systems brands. The company was incorporated in 1991 and is headquartered in Budapest, Hungary. Magyar Telekom Távközlési Nyilvánosan Müködö Részvénytársaság is a subsidiary of Deutsche Telekom Europe B.V.
Full MYTAY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.